Evidence map›Paper›PMID 25109237›Full record

ArticleMolecular and cellular neurosciences2014

N-myristoylation regulates the axonal distribution of the Fragile X-related protein FXR2P.

Emily E Stackpole, Michael R Akins, Justin R Fallon

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular neurosciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Chemical reporters for exploring protein acylation.Biochemical Society transactions · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Emily E StackpoleDepartment of Neuroscience, Brown University, Providence, RI 02912, USA.
Michael R AkinsDepartment of Neuroscience, Brown University, Providence, RI 02912, USA; Department of Biology, Drexel University, Philadelphia, PA 19104, USA.
Justin R FallonDepartment of Neuroscience, Brown University, Providence, RI 02912, USA. Electronic address: Justin_Fallon@brown.edu.
Brown University · USDrexel University · US

Funding

Experience-dependent regulation of the Fragile X geneR01HD052083 · NICHD · BROWN UNIVERSITY · PI FALLON, JUSTIN R. · 2006 to 2010
$1.3M
Presynaptic Fragile X ProteinsR00MH090237 · NIMH · DREXEL UNIVERSITY · PI AKINS, MICHAEL R · 2013 to 2015
$747k
Presynaptic Fragile X ProteinsK99MH090237 · NIMH · BROWN UNIVERSITY · PI AKINS, MICHAEL R · 2010 to 2011
$180k
NICHD NIH HHS HD052083NICHD NIH HHS R01 HD052083NIMH NIH HHS K99 MH090237NIMH NIH HHS MH090237NIMH NIH HHS R00 MH090237
6 · The paper itself

Abstract

Fragile X syndrome, the leading cause of inherited intellectual disability and autism, is caused by loss of function of Fragile X mental retardation protein (FMRP). FMRP is an RNA binding protein that regulates local protein synthesis in the somatodendritic compartment. However, emerging evidence also indicates important roles for FMRP in axonal and presynaptic functions. In particular, FMRP and its homologue FXR2P localize axonally and presynaptically to discrete endogenous structures in the brain termed Fragile X granules (FXGs). FXR2P is a component of all FXGs and is necessary for the axonal and presynaptic localization of FMRP to these structures. We therefore sought to identify and characterize structural features of FXR2P that regulate its axonal localization. Sequence analysis reveals that FXR2P harbors a consensus N-terminal myristoylation sequence (MGXXXS) that is absent in FMRP. Using click chemistry with wild type and an unmyristoylatable G2A mutant we demonstrate that FXR2P is N-myristoylated on glycine 2, establishing it as a lipid-modified RNA binding protein. To investigate the role of FXR2P N-myristoylation in neurons we generated fluorescently tagged wild type and unmyristoylatable FXR2P (WT and G2A, respectively) and expressed them in primary cortical cultures. Both FXR2P(WT) and FXR2P(G2A) are expressed at equivalent overall levels and are capable of forming FMRP-containing axonal granules. However, FXR2P(WT) granules are largely restricted to proximal axonal segments while granules formed with unmyristoylatable FXR2P(G2A) are localized throughout the axonal arbor, including in growth cones. These studies indicate that N-terminal myristoylation of the RNA binding protein FXR2P regulates its localization within the axonal arbor. Moreover, since FMRP localization within axonal domains requires its association with FXR2P, these findings suggest that FXR2P lipid modification is a control point for the axonal and presynaptic distribution of FMRP.

Indexed as

AnimalsAxonsBrainChlorocebus aethiopsCOS CellsFragile X Messenger Ribonucleoprotein 1Fragile X SyndromeMicrotubule-Associated ProteinsMyristatesNeuronsProtein Processing, Post-TranslationalFragile X Messenger Ribonucleoprotein 1Microtubule-Associated ProteinsMyristatesFragile X syndromeFXR2PMyristoylationRNA binding proteins

Identifiers

PMID25109237
PMCPMC4209718
OpenAlexW2025130505

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.